awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33429898-0391ECCE-2608-40FE-B85D-FA322DF336D8
Q33429898-0391ECCE-2608-40FE-B85D-FA322DF336D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429898-0391ECCE-2608-40FE-B85D-FA322DF336D8
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.
P2860
Q33429898-0391ECCE-2608-40FE-B85D-FA322DF336D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429898-0391ECCE-2608-40FE-B85D-FA322DF336D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96a07e995543ed69d05976610a7673a70f87f0c8
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.